Resolutions of the Annual General Shareholders’ Meeting of Sartorius AG

GÖTTINGEN, Germany, March 25, 2022 /PRNewswire/ — At present day virtual Yearly Normal Shareholders’ Assembly, the shareholders of Sartorius AG granted discharge to the Govt Board and the Supervisory Board and accepted the boards’ proposals by a large majority. They passed the resolution to pay back dividends of 1,26 euros for every desire share and 1.25 euros per ordinary share. The full quantity disbursed will be 85.9 million euros. In the earlier yr, dividends ended up .71 euros for each preference share and .70 euros for every everyday share.

During the typical election of shareholder reps to the Supervisory Board, shareholders re-elected Prof. David Raymond Ebsworth, Dr. jur. Daniela Favoccia, Dr. Lothar Kappich, Ms. Ilke Hildegard Panzer, and Prof. Dr. Klaus Rüdiger Trützschler. As Prof. Dr. Thomas Scheper was no for a longer period readily available for a more expression of business office, the Yearly General Shareholders’ Meeting elected electronic specialist Frank Riemensperger to the Supervisory Board as a shareholder representative. Riemensperger, who holds a degree in personal computer science, held senior administration positions at the consulting business Accenture for numerous years. The new Supervisory Board will provide for a expression of 5 a long time.

This push release is made up of ahead-searching statements about the future advancement of the Sartorius Team. Forward-hunting statements are topic to recognized and unknown threats, uncertainties and other things that could cause true success to differ materially from these expressed or implied by such statements. Sartorius assumes no liability for updating these statements in light of new data or long run activities. This is a translation of the initial German-language launch. Sartorius shall not assume any legal responsibility for the correctness of this translation. The primary German release is the lawfully binding version.

Added paperwork for the Yearly Normal Shareholders’ Assembly 2022:
https://www.sartorius.com/en/enterprise/trader-relations/sartorius-ag-trader-relations/shareholders-assembly

Tale continues

Supplemental one-way links
Once-a-year Report 2021
Present-day graphic documents

Financial calendar
April 21, 2022: Publication of initial-quarter figures (January to March 2022)
July 21, 2022: Publication of initially-fifty percent figures (January to June 2022)
October 19, 2022: Publication of nine-thirty day period figures (January to September 2022)

A profile of Sartorius

The Sartorius Team is a main worldwide associate of life science investigation and the biopharmaceutical field. With ground breaking laboratory instruments and consumables, the Group’s Lab Solutions & Solutions Division concentrates on serving the requirements of laboratories carrying out exploration and good quality command at pharma and biopharma firms and these of academic study institutes. The Bioprocess Methods Division with its wide products portfolio concentrating on one-use answers assists shoppers to manufacture biotech prescription drugs and vaccines properly and proficiently. The Team has been yearly expanding by double digits on regular and has been frequently increasing its portfolio by acquisitions of complementary systems. In fiscal 2021, the enterprise gained sales revenue of some 3.45 billion euros. At the conclude of 2021, just about 14,000 people today were being employed at the Group’s around 60 manufacturing and gross sales internet sites, serving consumers around the world.

Follow Sartorius on Twitter @Sartorius_Team and on LinkedIn.

Emblem – https://mma.prnewswire.com/media/1696516/Sartorius_Logo.jpg

For any inquiries remember to contact:
Timo Lindemann
[email protected]
+49 1709642070

Watch authentic content to down load multimedia:https://www.prnewswire.com/news-releases/resolutions-of-the-yearly-typical-shareholders-conference-of-sartorius-ag-301510838.html

Source Sartorius AG